rediff.com
X   
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Ajanta Pharma Ltd. - Research Center
532331 AJANTPHARM Group (A) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Quarterly results in brief
(Rs crore)
Jun' 14 Mar' 14 Dec' 13 Sep' 13 Jun' 13
Sales 287.49 311.05 300.85 279.83 218.94
Operating profit 89.70 110.55 97.22 84.16 51.09
Interest 1.42 2.20 2.18 2.21 1.63
Gross profit 96.97 111.39 99.07 88.25 56.32
EPS (Rs) 16.61 19.83 17.66 15.79 13.78
Quarterly  results in details
Jun' 14 Mar' 14 Dec' 13 Sep' 13 Jun' 13
Other income 8.69 3.04 4.03 6.30 6.86
Stock adjustment 12.48 -31.57 -4.69 27.26 16.14
Raw material 57.82 105.86 86.02 57.16 50.83
Power and fuel - - - - -
Employee expenses 42.84 37.67 38.38 37.35 33.85
Excise - - - - -
Admin and selling expenses - - - - -
Research and development expenses - - - - -
Expenses capitalised - - - - -
Other expenses 84.65 88.54 83.92 73.90 67.03
Provisions made - - - - -
Depreciation 12.04 14.89 9.49 8.99 8.60
Taxation 26.21 26.41 27.16 23.45 15.18
Net profit / loss 58.72 70.09 62.42 55.81 32.54
Extra ordinary item - - - - -
Prior year adjustments - - - - -
Equity capital 17.68 17.67 17.67 17.67 11.81
Equity dividend rate - - - - -
Agg.of non-prom. shares (Lacs) 93.05 92.79 92.79 92.79 62.19
Agg.of non promotoholding (%) 26.45 26.40 26.40 26.40 26.54
OPM (%) 31.20 35.54 32.32 30.08 23.34
GPM (%) 32.74 35.46 32.49 30.84 24.94
NPM (%) 19.83 22.32 20.47 19.51 14.41
Close
Add Ajanta Pharma Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Ajanta Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close